We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
+4.88%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$197M
AUM Growth
-$21.3M
(-9.8%)
Cap. Flow
-$17.6M
Cap. Flow
% of AUM
-8.93%
Top 10 Holdings %
Top 10 Hldgs %
62.37%
Holding
44
New
8
Increased
13
Reduced
17
Closed
5
Top Buys
| 1 |
Kura Oncology
KURA
|
+$11.5M |
| 2 |
Q32 Bio
QTTB
|
+$8.06M |
| 3 |
uniQure
QURE
|
+$7.65M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.94M |
| 5 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$5.92M |
Top Sells
| 1 |
Cigna
CI
|
+$16.7M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$9.43M |
| 3 |
HNGR
Hanger Inc.
HNGR
|
+$8.55M |
| 4 |
Iovance Biotherapeutics
IOVA
|
+$7.79M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
+$7.33M |
Sector Composition
| 1 | Healthcare | 98.13% |
| 2 | Technology | 0.92% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zimmer Biomet
ZBH
$17.6B
| $19.4M | 9.86% |
169,558
+42,353
| +33% | +$4.96M |
|
|
2
Bristol-Myers Squibb
BMY
$119B
| $18.6M | 9.47% |
410,490
+127,490
| +45% | +$5.94M |
|
|
3
Kura Oncology
KURA
$998M
| $17.1M | 8.69% |
867,810
+694,916
| +402% | +$11.5M |
|
|
RETA
4
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $11.8M | 5.99% |
124,965
-50,735
| -29% | -$4.38M |
|
|
5
Iovance Biotherapeutics
IOVA
$1.93B
| $9.81M | 4.99% |
400,000
-517,080
| -56% | -$7.79M |
|
|
ARNA
6
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $9.63M | 4.9% |
164,300
-88,200
| -35% | -$4.56M |
|
|
HNGR
7
DELISTED
Hanger Inc.
HNGR
| $9.42M | 4.79% |
491,685
-441,863
| -47% | -$8.55M |
|
|
8
uniQure
QURE
$2.79B
| $9.38M | 4.77% |
+120,000
| New | +$7.65M |
|
9
UroGen Pharma
URGN
$1.94B
| $9.38M | 4.77% |
260,928
+103,066
| +65% | +$3.8M |
|
|
ALBO
10
DELISTED
Albireo Pharma Inc
ALBO
| $8.17M | 4.15% |
253,327
-16,509
| -6% | -$552K |
|
|
SBBP
11
DELISTED
Strongbridge Biopharma plc.
SBBP
| $7.97M | 4.05% |
2,546,997
+1,613,121
| +173% | +$5.92M |
|
|
12
Q32 Bio
QTTB
$289M
| $7.22M | 3.67% |
+20,503
| New | +$8.06M |
|
|
CLVS
13
DELISTED
Clovis Oncology, Inc.
CLVS
| $6.69M | 3.4% |
450,000
+200,611
| +80% | +$3.62M |
|
14
Centene
CNC
$33.1B
| $6.63M | 3.37% |
126,500
+48,100
| +61% | +$2.6M |
|
|
15
Cigna
CI
$79.6B
| $4.92M | 2.5% |
31,227
-106,773
| -77% | -$16.7M |
|
16
BioMarin Pharmaceuticals
BMRN
$11.4B
| $4.38M | 2.23% |
51,200
-6,184
| -11% | -$529K |
|
17
Aldeyra Therapeutics
ALDX
$115M
| $4.19M | 2.13% |
697,921
+114,621
| +20% | +$863K |
|
18
Gyre Therapeutics
GYRE
$732M
| $4.03M | 2.05% |
72,946
+8,386
| +13% | +$524K |
|
19
Indaptus Therapeutics
INDP
$384M
| $3.54M | 1.8% |
364
+122
| +50% | +$1.54M |
|
20
AC Immune
ACIU
$242M
| $3.13M | 1.59% |
563,900
-146,641
| -21% | -$747K |
|
21
Assembly Biosciences
ASMB
$531M
| $2.7M | 1.37% |
16,667
-9,534
| -36% | -$1.81M |
|
|
TLGT
22
DELISTED
Teligent, Inc
TLGT
| $1.87M | 0.95% |
296,772
-7,385
| -2% | -$60.2K |
|
|
WCG
23
DELISTED
Wellcare Health Plans, Inc.
WCG
| $1.85M | 0.94% |
6,500
-34,200
| -84% | -$9.43M |
|
|
EFOR
24
Everforth Inc
EFOR
$722M
| $1.82M | 0.92% |
30,000
-79,116
| -73% | -$4.75M |
|
|
MTEM
25
DELISTED
Molecular Templates, Inc.
MTEM
| $1.65M | 0.84% |
13,179
-6,674
| -34% | -$725K |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA